MGNX

NASDAQStock

MacroGenics, Inc.

$3.00-0.13 (-4.01%)

52-Week Range

$1.06

$3.43

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.39

Volume

901.3K

Avg Volume

2.0M

Performance

+82.46%

+127.74%

+100.00%

YTD

+93.79%

+40.54%

-50.79%

-89.78%

Price Chart

ETF Exposure

MGNX is held by 13 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
CNCR	Loncar Cancer Immunotherapy ETF	3.17%	71,307	$851K	$12.7M	0.79%
IWC	iShares Micro-Cap ETF	0.04%	158,048	$528K	$1.27B	0.60%
PRFZ	Invesco RAFI US 1500 Small-Mid ETF	0.01%	112,241	$375K	$2.67B	0.34%
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	25,346	$79K	$2.36B	0.25%
VHT	Vanguard Health Care ETF	0.00%	155,780	$285K	$19.80B	0.09%
VXF	Vanguard Extended Market ETF	0.00%	651,752	$1.2M	$84.10B	0.05%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	1,871	$6K	$40.55B	0.17%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	94	$234	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	3,382	$8K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	16	$40	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,925,510	$3.5M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	10,127	$25K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	873	$2K	$1.29B	0.17%

About MGNX ETF Exposure

MacroGenics, Inc. (MGNX) is held by 13 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $3.00. Investors can gain exposure to MGNX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MGNX, sorted by portfolio weight.